一项质量改进项目:优化经导管主动脉瓣植入术前CT的全身动脉对比剂强化
该质量改进项目针对TAVI术前CT,将对比剂方案优化为30秒团注、碘流量15-19 mg碘/kg体重/秒。与31例标准方案相比,31例优化方案在非门控采集的升主动脉、降胸主动脉(隆突水平)、肾下腹主动脉和右髂总动脉各点强化均改善(p<0.002),门控升主动脉强化无差异(p>0.99)。
要点
- 优化方案为30秒对比剂团注、碘流量15-19 mg碘/kg体重/秒。
- 非门控采集各动脉点强化均改善(p<0.002),门控升主动脉无差异。
- 优化方案团注持续时间30±0.3秒,标准方案24.9±4.4秒(p<0.001)。
核心结论
- 优化对比剂流量并使团注持续时间与CT技术匹配,可显著改善TAVI术前CT规划中的血管入路评估,为血流动力学脆弱患者提供可靠的动脉强化方法且不增加对比剂用量。
研究设计与样本
- 质量改进项目,比较31例连续优化方案检查与31例既往标准方案检查,测量门控收缩期升主动脉及非门控升主动脉、降胸主动脉(隆突水平)、肾下腹主动脉和右髂总动脉的强化(平均HU)。
诊断标准与关键数值
- 优化方案:30秒对比剂团注,碘流量15-19 mg碘/kg体重/秒。
- 非门控采集各解剖点强化改善(p<0.002),门控升主动脉强化无差异(p>0.99)。
- 团注持续时间:标准方案24.9±4.4秒 vs 优化方案30±0.3秒(p<0.001)。
临床应用与阅片要点
- 优化对比剂流量和团注持续时间可改善TAVI术前CT的动脉强化,适用于血流动力学脆弱患者。
- 作者指出优化方案可在不过量使用对比剂的情况下获得良好动脉强化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess improvement in arterial opacification by optimising the contrast medium dosing protocol for computed tomography (CT) prior to trans-catheter aortic valve implantation (TAVI).
MATERIALS AND METHODS: A wide variation in arterial opacification was observed in the initial CT TAVI protocol (standard protocol). The practice was optimised by considering the time required for the examination and optimising contrast medium flux. This became the optimised protocol with a 30-second contrast medium bolus of iodine flux 15-19 mg iodine/kg body weight/second (mg/kg/s). Attenuation (mean HU) in (a) the ascending aorta (gated systolic acquisition) and (b) the ascending, descending thoracic (at carina), infra-renal abdominal aorta, and right common iliac artery (non-gated acquisition) was measured. Thirty-one sequential optimised examinations were compared to 31 prior standard protocol examinations.
RESULTS: There was no difference between the standard and optimised groups regarding age, sex, weight, body mass index (BMI), or voltage. The mean bolus durations were 24.9±4.4 seconds for the standard and 30±0.3 seconds for the optimised protocols (p<0.001). Although there was no difference in the attenuation in the gated ascending aorta (p>0.99), there was improvement at all other anatomical points in the non-gated examinations of the optimised protocol (p<0.002).
CONCLUSION: Optimising contrast medium flux and matching bolus duration to the CT technology dramatically improves the vascular access component of TAVI planning and provides a reliable method to achieve objectively enhanced arterial opacification. This work highlights how to obtain good arterial contrast medium opacification in haemodynamically fragile patients without excessive contrast medium volumes.
引用
- Komber, Neumann, Paull, et al. A quality-improvement project to enhance systemic arterial contrast opacification in CT for trans-catheter aortic valve implantation. Clin Radiol. 2022. PMID: 35717408. doi:10.1016/j.crad.2022.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。